APA (7th ed.) Citation

A, D., AH, K., MH, S., W, G., PYF, Z., SEB, R., . . . AC, N. (2024). Loss of MACROD2 drives radioresistance but not cisplatin resistance in HPV-positive head and neck cancer. Oral oncology, 159, 107061. https://doi.org/10.1016/j.oraloncology.2024.107061

Chicago Style (17th ed.) Citation

A, Dawson, et al. "Loss of MACROD2 Drives Radioresistance but Not Cisplatin Resistance in HPV-positive Head and Neck Cancer." Oral Oncology 159 (2024): 107061. https://doi.org/10.1016/j.oraloncology.2024.107061.

MLA (9th ed.) Citation

A, Dawson, et al. "Loss of MACROD2 Drives Radioresistance but Not Cisplatin Resistance in HPV-positive Head and Neck Cancer." Oral Oncology, vol. 159, 2024, p. 107061, https://doi.org/10.1016/j.oraloncology.2024.107061.